This case describes a woman in her mid-40s with recurrent colorectal cancer who developed severe dermatologic toxicity during panitumumab-based therapy. Three months after treatment initiation, she ...

Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor–Positive, Early-Stage Breast Cancer Multicenter prospective ...

Please provide your email address to receive an email when new articles are posted on . Acute MI survivors reported continued fear of a recurrence 6 months and 8 months later. Perceived stress was ...

The presence of circulating tumor DNA (ctDNA) in patients with human epidermal growth factor receptor 2 (HER2)-positive ...

The Signatera assay showed positive correlations between ctDNA presence and cancer recurrence, suggesting its potential for ...

Although 76% respondents reported encountering medical misinformation, that exposure was not significantly associated with clinically significant fear of cancer recurrence or self-reported treatment ...

Several factors can influence a person’s life expectancy if they experience recurrence of pancreatic cancer, including the location of recurrence, a person’s treatment, and their tumor grading, size, ...

Postdiagnosis exercise is associated with lower breast cancer (BC) mortality but its link with risk of recurrence is less clear. We investigated the impact and dose-response relationship of exercise ...